The Federal University of Rio de Janeiro or University of Brazil is a public research university located in the state of Rio de Janeiro, Brazil. It is the largest federal university in the country and is one of the Brazilian centers of excellence in teaching and research.

During the past decade, Universidade Federal do Rio de Janeiro conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidade Federal do Rio de Janeiro" #1 sponsor was "Universidade Federal do Rio de Janeiro" with 27 trials, followed by "Takeda" with 3 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored, "Alexandre Guedes Torres" with 1 trials sponsored and "Centers for Disease Control and Prevention" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Federal do Rio de Janeiro" #1 collaborator was "Rio de Janeiro State Research Supporting Foundation (FAPERJ)" with 8 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 5 trials as a collaborator, "Universidade Federal do Rio de Janeiro" with 4 trials as a collaborator, "Ministry of Science and Technology, Brazil" with 3 trials as a collaborator and "National Research Council, Brazil" with 3 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Universidade Federal do Rio de Janeiro" are "Aging" (3 trials), "Covid19" (3 trials), "Amyloidosis" (2 trials), "FAP" (2 trials) and "Familial Amyloid Polyneuropathy" (2 trials). Many other conditions were trialed in "Universidade Federal do Rio de Janeiro" in a lesser frequency.

Most popular intervention types in "Universidade Federal do Rio de Janeiro" are "Drug" (21 trials), "Other" (6 trials), "Behavioral" (5 trials), "Dietary Supplement" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Computerized cognitive training" (3 trials), "Inotersen" (2 trials), "Nitazoxanide" (2 trials) and "0.9% sodium chloride (NaCl) saline solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidade Federal do Rio de Janeiro" are 41 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universidade Federal do Rio de Janeiro". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Universidade Federal do Rio de Janeiro, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidade Federal do Rio de Janeiro, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".

Universidade Federal do Rio de Janeiro has several departments that took part in Clinical trials: "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" - 15 trials